Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Unknown 5Recruiting 5Withdrawn 4Active not recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 5INDUSTRY 2

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Tumor-Agnostic 1Thoracic 1Other hematologic neoplasm 1

Conditions

Neoplasms 1Hematologic Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Adenocarcinoma of Lung 1

Interventions

Cisplatin 349Oxaliplatin 260Capecitabine 258Radiotherapy 238Gemcitabine 221Docetaxel 221Carboplatin 220Drug Therapy 216Cyclophosphamide 216apatinib 200Paclitaxel 199Bevacizumab 194camrelizumab 189Fluorouracil 187sintilimab 131Irinotecan 125Blood Specimen Collection 124Dexamethasone 122Etoposide 118toripalimab 115Surgical Procedures, Operative 115Radiosurgery 114pembrolizumab 111Pemetrexed 108anlotinib 105S 1 (combination) 105Leucovorin 101Surveys and Questionnaires 98tislelizumab 96Doxorubicin 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × OTHER × Thymalfasin × Clear all
NCT06024356 2023-09-06

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for Locally Advanced Mid-low Rectal Cancer

Beijing Friendship Hospital

Unknown
26 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05790447 2023-03-30

Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors

Second Affiliated Hospital of Soochow University

Phase 2 Unknown
60 enrolled
Tumor-Agnostic

Neoplasms

NCT02545751 2017-11-28

SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer

Hangzhou Cancer Hospital

Phase 2 Unknown
29 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02787447 2016-11-25

Radiotherapy Combined With Thymosin for Metastatic NSCLC Patients Who Showed Stable Disease After First Line TKI Therapy

First People's Hospital of Hangzhou

Phase 2 Unknown
46 enrolled
Thoracic

Adenocarcinoma of Lung

NCT00580450 2007-12-24

Thymosin Alfa 1 in Recipients of Allogeneic Hematopoietic Transplantation for Hematological Malignancies

University Of Perugia

Phase 1/2 Unknown
9 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡